<<>>>
TitleUrlVersionPublisher
All Cancerhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.108.12.101120170504NCQA PHEMUR
Eyelid or Orbital Conditionshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.8420.3.100820190920AOA MORE Steward
Child Influenza Vaccinehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.122020220209NCQA PHEMUR
ActRelationshipTemporallyPertainsEndhttp://terminology.hl7.org/ValueSet/v3-ActRelationshipTemporallyPertainsEnd2.0.0
Chemotherapy for Colon Cancer - Leucovorin and Levo-Leucovorin Ingredienthttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.191620170926PCPI Steward
Malignant Neoplasm of Pancreashttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.102520200715Lewin EH Steward
Lyme Disease and other Arthropod-Borne Diseaseshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.101520180310NCQA PHEMUR
Creatinine (Tests in Serum by Any Method)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.220620230602CSTE Steward
Localized Bladder Cancer N Stagehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1260.12020240216CancerLinQ Steward
Cancer Stage M1http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.24120220112American Society of Clinical Oncology Steward
Consult Infectious Diseasehttp://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.66120190419ECRI Steward
Fatal Familial Insomnia (Disorders) (ICD10CM)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.213420230122CSTE Steward
Rhabdomyolysishttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.8920170504Mathematica
Cyclosporiasis (Organism or Substance in Lab Results)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.37520230122CSTE Steward
Reasons for Interventions Related to Medication Management, Dose Too Highhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.920190605PharmacyHIT
Patient with Documented Cognitive Challengeshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.1002.3320151013Lewin EH Steward
Gestational Age 37-38 weekshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.28720130401Joint Commission
BH Electroconvulsive therapy SNOMEDhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1257.1.179920170504CQAIMH Steward
S4G Hamartomahttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.129820220826Elimu Informatics Steward
Housing Instability Procedureshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1247.4420240604The Gravity Project Steward
Focal Neurological Deficithttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.17.4077.3.103320201231ACEP/AMA-PCPI Steward
Erythrocyte Distribution Widthhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.14720200425HL7 Patient Care WG Steward
Recommendation for Physical Activityhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.34120190108Oncology Nursing Society Steward
Alcohol Brief Intervention and Counselinghttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.10820200609MITRE Steward
hl7VS-rxComponentTypehttp://terminology.hl7.org/ValueSet/v2-01662.0.0HL7, Inc
Cerebrospinal fluid pleocytosis (SNOMED)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.156020220119CSTE Steward
COVID19 SNOMED Value Set for Glomerulonephritishttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.612320221210Clinical Architecture
Cannabidiol containing compoundshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.9920230227Meaningful Drug Interaction Alerts Steward
NU_Hypersomnia [Unspecified] (ICD10CM)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.141320210721CSTE Steward
Leukocyte Esterasehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.17.4077.3.202720181214ACEP/AMA-PCPI Steward
<<>>>653654655656657<<>>>